What Norbrook does

Norbrook Laboratories Limited is a family-owned veterinary pharmaceutical manufacturer founded in 1969 in Newry, Northern Ireland, by the late Lord Ballyedmond, now led by Executive Chairman Liam Nagle (appointed 2015) following Ballyedmond's death in 2014. The company develops, manufactures and sells differentiated generic animal health products — antibiotics, anti-inflammatories, parasiticides, intramammaries, metabolic supplements and specialty formulations (e.g. Closamectin, Hexasol LA, Alamycin, Loxicom, Felanorm/Thyronorm) — across species segments for beef and dairy cattle, sheep, pigs, horses, dogs and cats, with 3,000+ product registrations sold in 100+ countries.

The company operates three manufacturing sites in Newry (Station Works, Carnbane Industrial Estate, Armagh Road), a manufacturing facility in Nairobi, Kenya (operational since 1993, today No. 1 animal health position in East Africa) and additional sites; vertical integration includes in-house API manufacturing since 1994. Facilities are audited and approved by the US FDA, UK VMD and EMA, and Norbrook remains one of the few non-US manufacturers FDA-authorized to import sterile injectables into the United States. The R&D engine has produced 24 product launches in the last five years with a further 10 scheduled in the next three, including multiple 'global first' formulations (Closamectin Ivermectin+Closantel pour-on, Hexasol LA, Felanorm liquid methimazole) and a 2024 entry into cattle diagnostics with the Liver Fluke Rapid Antibody Test.

Revenue is generated primarily through veterinary professional prescription channels (POM-V prescription-only medicines), distributed via direct field-based sales teams in the US, UK, Ireland, Australia, New Zealand and East Africa, and via distributor partners in Europe and MENA, with regional sales-and-marketing leaders covering seven global territories. Disclosed revenue of £200m for the year to 2 August reflects a £19m year-on-year decline driven by a two-month FDA-audit-related production stoppage and a £20.3m loss, against £120m of cumulative capex since 2016 and continued product pipeline reinvestment.

Name

Norbrook

Legal name

Norbrook Laboratories Limited

Website

https://norbrook.com

Company type

Private

Founded year

1969

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Norbrook is a Northern Ireland-headquartered, family-owned veterinary pharmaceutical company that develops, manufactures and distributes differentiated generic animal health medicines and diagnostics for livestock and companion animals across 100+ countries.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM)

akta.pro secondary industries

Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA), Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid) (HLAMAEAG), Veterinary Vaccine & Biologics Distributors (HLAMAIAC)

Keywords

• Veterinary pharmaceuticals
• Animal health medicines
• Differentiated generic drugs
• Sterile injectables manufacturing
• Livestock parasite control

Headquarters

HQ city

Newry

HQ country

United Kingdom

HQ region

Europe

Offices9 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations

Revenue model

1. Veterinary Pharmaceutical Products Sales: Sale of differentiated generic veterinary pharmaceutical products for farm animals (cattle, sheep, pigs, horses) and companion animals (dogs, cats). Products include antibiotics, anti-inflammatories, parasiticides, and specialty treatments sold to veterinarians, farmers, and pet owners across 100+ countries.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Norbrook manufactures and globally distributes differentiated generic veterinary pharmaceutical products for farm animals (cattle, sheep, pigs, horses) and companion animals (dogs, cats), including antibiotics, anti-inflammatories, parasiticides, intramammaries, metabolic treatments, diagnostic tests, and specialty formulations. Products are sold in over 100 countries through wholly owned subsidiaries and distributor networks to veterinary professionals who prescribe and dispense them to farmers and pet owners.

Product overview

Norbrook is a veterinary pharmaceutical company offering a broad portfolio of differentiated generic animal health products spanning farm animals (beef cattle, dairy cattle, sheep, pigs, horses) and companion animals (dogs, cats). The portfolio includes antibiotics (e.g., Alamycin LA 300, Betamox Injection, Noroclav), anti-inflammatories and pain management (Loxicom family, Pyroflam), parasiticides (Closamectin Pour-On, Noromectin family, Paramectin, Spotinor, Solantel), intramammary products (Bovaclox DC Xtra, NoroSeal, Multiject), diagnostic tests (Liver Fluke Rapid Antibody Test), nutritional and metabolic supplements (Calciject, Calcitrace, Ketonor, Life-Aid Xtra), and specialty formulations (Thyronorm for feline hyperthyroidism, Felanorm methimazole oral solution, Peptizole for equine gastric ulcers). The company also manufactures active pharmaceutical ingredients (APIs) internally. Norbrook's products are sold across 100+ countries, with key markets including the US, UK, Ireland, Australia, New Zealand, Europe, MENA, East Africa, and Latin America.

Differentiator

Problem solved

Functional benefit

Brands

• Closamectin: Global first for a cattle flukicide available as a pour on; one of Norbrook's leading global products for treatment of fluke and worms.
• Thyronorm
• Alamycin LA 300
• Hexasol LA Injection
• Felanorm

Products and services

• Closamectin Pour-On Pour-on parasiticide for cattle combining Ivermectin and Closantel, providing fluke and worm treatment in a single application. For use by veterinary professionals and farmers.
• Closamectin Injection for Sheep Injectable parasiticide for sheep delivering flukicide and wormer activity in a single dose.
• Felanorm (Methimazole) Oral Solution Differentiated generic methimazole oral solution for the treatment of feline hyperthyroidism in cats, launched in the US market.
• Thyronorm (Methimazole) Oral Solution Global-first liquid therapy for the treatment of feline hyperthyroidism in cats.
• Firox Chewable Tablets for Dogs Chewable tablet formulation launched in the US market in 2022 for dogs, one of five FDA approvals secured by Norbrook that year.
• Hexasol LA Injection Long-acting combination injection of antimicrobial and non-steroidal anti-inflammatory drug in a single injection, representing a global-first combination product.
• Alamycin LA 300 Long-acting oxytetracycline antibiotic injection with multiple routes of administration and target species.
• Liver Fluke Rapid Antibody Test Ground-breaking rapid antibody diagnostic test for liver fluke in cattle, launched in October 2024.
• Loxicom (Meloxicam) Range Family of meloxicam-based NSAIDs available as oral suspensions for dogs and cats, an injection for dogs and cats, and a long-acting injection for cattle, pigs, and horses. Used for pain management and inflammation across species.
• Noromectin (Ivermectin) Range Ivermectin parasiticide family available as pour-on, drench, equine paste, and multi injection formulations for cattle, sheep, and horses.
• Betamox (Amoxicillin) Range Amoxicillin antibiotic range including standard and long-acting injections for livestock and companion animals.
• Noroclav (Amoxicillin + Clavulanic Acid) Range Amoxicillin-clavulanic acid combination antibiotic available as injection for cattle and dogs and as palatable tablets for dogs.
• Combiclav Injection and Intramammary Range Amoxicillin-clavulanic acid combination products available as injection and as lactating cow intramammary suspension.
• Bovaclox DC Xtra and Intramammary Range Dry cow intramammary antibiotic range for mastitis management, including Bovaclox DC Xtra, Noroclox DC, Cepritect, Multiject, NoroSeal, and Combiclav Lactating Cow.
• Solantel Pour-On and Drench (Closantel) Closantel flukicide available as 200mg/ml pour-on solution and drench for cattle and sheep liver fluke control.
• Spotinor and Moxiclear Spot-On Solutions Topical spot-on parasiticides for cattle and cats, including deltamethrin-based and imidacloprid/moxidectin combinations.
• Calciject 40 CM and Calcium/Magnesium Bolus Range Calcium, magnesium, and phosphorus injectable and bolus supplements for dairy cattle, including Calciject 40 CM, Calcitrace D3, Calcitrace P Liquid, Magniject, Opti-Mag 3, Norophos, and Ketonor.
• Levacide and Levafas Range (Levamisole) Levamisole-based anthelmintics available as injection, low-volume drench, and Levafas Diamond drench for livestock worm control.
• Peptizole Oral Paste for Horses Oral paste for treatment of equine gastric ulcer syndrome.
• Betafuse Gel for Dogs Topical betamethasone and fusidic acid gel for canine inflammatory skin conditions including pyoderma.
• Alamycin Aerosol and Other Topical Antibiotic Formats Topical oxytetracycline aerosol and other surface-applied antibiotic preparations for livestock wound and surface infection management.
• Colvasone (Dexamethasone) Injection Corticosteroid injection for anti-inflammatory and supportive therapy in livestock and horses.
• Pyroflam (Ketoprofen) Injection Non-steroidal anti-inflammatory injection for livestock pain and inflammation management.
• Carprieve (Carprofen) Range Carprofen NSAID range available as injection for cattle and as tablets for dogs, used for pain and inflammation management.
• Norodine 24 and Trimethoprim-Sulfa Range Potentiated sulphonamide antibiotic range including Norodine 24 injection and Norodine Equine oral paste.
• Lincoject, Norfenicol, Marbonor, Norocillin, Pen and Strep Range Range of livestock antibiotic injections including lincomycin, florfenicol, marbofloxacin, penicillin, and penicillin/streptomycin combinations.
• Enovex Pour-On, Eprizero, Paramectin, Taurador Range Additional pour-on parasiticide brands including abamectin and eprinomectin-based pour-on formulations for cattle.
• Life-Aid Xtra Oral Rehydration Oral rehydration powder for calves and livestock, sold in sachet format for calf scours management.
• Opticlox Eye Ointment Ophthalmic cloxacillin ointment for treatment of eye infections in livestock.
• Tulieve Injection Tulathromycin injectable antibiotic for bovine respiratory disease and swine respiratory disease.
• Ultrapen LA Injection Long-acting procaine penicillin injection for livestock.
• Noropraz Oral Paste for Horses Oral paste parasiticide product for horses.
• Adrenacaine Injection Adrenaline and procaine combination injection for local anaesthesia in veterinary procedures.
• Active Pharmaceutical Ingredient (API) Manufacturing In-house manufacturing of Active Pharmaceutical Ingredients since 1994, producing a large percentage of Norbrook's finished product API requirements.

Quantifiable outcome

• FDA approval for 5 products in 2022 - highest number of generic FDA approvals that year
• +4 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• US Food and Drug Administration (FDA)coreOthers · 1 January 1987FDA granted approval in 1987 for Norbrook to manufacture sterile injectables at Station Works factory in Newry for sale in the US market. Norbrook remains one of the few companies manufacturing outside the United States authorized by the FDA to import sterile injectables into the US.

Scale indicators13 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Virbac: Virbac is an independent French animal health company offering pharmaceuticals, vaccines, and diagnostics with a similar differentiated generics and specialty positioning. Directly comparable business model and global footprint.
• Ceva Santé Animale: Ceva is a large independent global animal health company focused on pharmaceuticals, vaccines, and companion/specialty products. Comparable diversified vet pharma strategy with strong emerging-market presence like Norbrook.
• Dechra Pharmaceuticals: Dechra was a UK-headquartered veterinary pharmaceuticals company specializing in companion animal and equine products prior to its 2024 acquisition by EQT. Closest UK/European comparable to Norbrook's specialty pharma focus.
• Phibro Animal Health: Phibro is a global animal health and nutrition company offering pharmaceuticals, vaccines, and specialty ingredients with a similar differentiated generics and livestock focus. Closely comparable scale and operating model.
• Vetoquinol: Vetoquinol is an independent, family-influenced French veterinary pharmaceutical company with a comparable focus on differentiated generics and specialty therapeutics across farm and companion animals. Closest scale and strategy match to Norbrook among privately held peers.
• Bimeda: Bimeda is a privately held global veterinary pharmaceuticals company with manufacturing and distribution across livestock and companion animal segments. Comparable family-influenced private competitor with differentiated generics strategy.

Broad incumbents

• Zoetis: Zoetis is the world's largest pure-play animal health company, offering pharmaceuticals, vaccines, diagnostics, and diagnostics across companion and livestock animals. It is a clear industry leader and the most relevant broad incumbent for Norbrook's diversified vet pharma portfolio.
• Elanco Animal Health: Elanco is a top-tier global animal health company with broad pharmaceutical, vaccine, and pet therapeutic offerings. Comparable to Norbrook across farm and companion animal segments with significant US overlap.
• Boehringer Ingelheim Animal Health: Boehringer Ingelheim's animal health division is one of the largest globally, spanning vaccines, parasiticides, and therapeutics for companion and production animals. Comparable broad incumbent with overlapping livestock and companion product lines.

Regional players

• Chanelle Pharma: Chanelle is an Irish veterinary pharmaceuticals manufacturer with strong European generics focus. Comparable product overlap and Irish/UK regional presence to Norbrook though smaller in scale and geographic reach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/norbrook-laboratories-ltd

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Norbrook